C
IPSC
Century Therapeutics, Inc.
2.020
-0.090-4.27%After Hours: 2.050 +0.030 +1.49%18:23 08/20 EDT
OPEN/PREV CLOSE2.070/2.110
TODAY RANGE2.019-2.090
VOL314.08K
MARKET CAP365.77M
52 WEEK RANGE0.4350-3.040
AVG VOL (3M)1.22M
% TURNOVER0.17%
TURNOVER--
P/E (TTM)-2.2507
% RANGE3.36%
EPS(TTM)-0.8975
P/E(FORWARD)-3.8846
P/B1.570
BVPS1.287
DIVIDEND--
P/S1.619
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP335.91M
SHARES OUTSTANDING181.08M
NEXT EARNINGS11/11-11/16
FREE FLOAT166.29M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/13 07:18
Clear Street Sticks to Its Buy Rating for Century Therapeutics (IPSC)
NASDAQ·08/12 18:02
Century Advances CNTY-813; IND Submission On Track For Q4 2026
TipRanks·08/12 12:48
Century Therapeutics Reports Q2 Results, Pipeline Advancements
Benzinga·08/12 12:05
Century Therapeutics Q2 EPS $(0.17) Misses $(0.14) Estimate
Seeking Alpha·08/12 12:03
Century Therapeutics GAAP EPS of -$0.17 misses by $0.05
Dow Jones·08/12 12:01
*Century Therapeutics 2Q Loss/Shr 17c >IPSC
Dow Jones·08/12 12:01
*Century Therapeutics 2Q Rev $0.00 >IPSC
Dow Jones·08/12 12:00
Press Release: Century Therapeutics Reports -2-
Seeking Alpha·07/09 17:41
Century: 'Hold' Based On CNTY-101 Pivot And CNTY-813 T1D Curative Potential
Benzinga·06/30 12:03
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Benzinga·06/26 14:18
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
Same Industry
Name/Symbol
Change%
Price